Pioneer Institute’s Life Sciences Initiative (PLSI) aims to increase public understanding of the life sciences ecosystem and offer policy options to expand patient access to breakthrough therapies without harming the very ecosystem that makes those breakthroughs possible.
Experts
William S. Smith is Director of the Life Sciences Initiative at Pioneer Institute. He has 25 years of experience in government and in corporate roles, including as vice president of public affairs and policy at Pfizer, and as a consultant to major pharmaceutical, biotechnology and medical device companies. He held senior staff positions for the Republican House leadership on Capitol Hill, the White House, and in the Massachusetts Governor’s office. He earned his PhD with distinction at The Catholic University of America (CUA).
Dr. Robert Popovian is Visiting Fellow with Pioneer Institute’s Life Sciences Initiative. He is the Founder of the strategic consulting firm Conquest Advisors, and previously served as Vice President, U.S. Government Relations at Pfizer. Dr. Popovian has published extensively and has delivered briefings, and expert reviews for the U.S. Congress, state legislatures, and at national and global conferences. He was recently appointed as the Chief Science Policy Officer for Global Healthy Living Foundation. He completed his Doctorate in Pharmacy and Master of Science in Pharmaceutical Economics and Policy degrees at the University of Southern California with honors; and a residency in Pharmacy Practice/Adult Internal Medicine and Infectious Diseases at the Los Angeles County-USC Hospital and fellowship in Pharmaceutical Economics and Policy at USC.
Get Updates on our Work to Protect Patients and Innovation!
Get Updates on our Work to Protect Patients and Innovation!
Read Pioneer Institute Research:
Recent Media Coverage:
TAKE ACTION TO PROTECT PATIENTS AND INNOVATION:
Click here to download our digital advocacy toolkit of social media, email, and website content resources to share information on how ICER threatens patients and innovation.
Read Research From Other Experts:
November 6, 2019
National Council on Disability (NCD): Quality-Adjusted Life Years and the Devaluation of Life with Disability
April 23, 2019
MacIver Institute: Issue Brief – Problems With The Institute of Clinical and Economic Review (ICER) and the QALY Methodology
March 20, 2019
Xcenda: Applying ICER Assessments in Medicaid Could Limit Patients’ Access to Medicines